Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weifuchun Capsule for Chronic Atrophic Gastritis (Phase 4, randomized double-blind study)
ChiCTR2000041504Phase 4Recruiting
- Sponsor
- Zhejiang Hospital of Traditional Chinese Medicine
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of weifuchun in atrophic gastritis (AG) (2 arms), sponsored by Zhejiang Hospital of Traditional Chinese Medicine. Primary endpoint: Histopathology of gastric mucosal atrophy. Started Nov 2020; status: recruiting.
02
Drugs
weifuchun
03
Conditions
atrophic gastritis (AG)
Beyond the preview
Go deeper on ChiCTR2000041504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000041504.